Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Open Label Non-Randomized Phase II Study Exploring «Chemo-Free » Treatment Association with Idelalisib + Obinutuzumab in Patients with Relapsed/Refractory (R/R) Waldenstrom's Macroglobulinemia (MW), a Filo Trial: Results of the Intermediary Analysis of the Induction Phase

Cecile Tomowiak, MD, Kristell Desseaux, Stéphanie Poulain, MD PhD, Charles Herbaux, MD, Aurore Perrot, MD PhD, Beatrice Mahe, MD, Pierre Morel, MD, Olivier Tournilhac, Stephane Lepretre, MD, Thérèse Aurran, MD, Bruno Villemagne, MD, Olivier Casasnovas, MD, Delphine Nollet, Brigitte Dreyfus, MD, Sylvie Chevret, MD PhD, Veronique Leblond, MD PhD

Blood (2019) 134 (Supplement_1): 346.

https://doi.org/10.1182/blood-2019-122826

Published: 2019

Journal Articles

Predicting the Long-Term Efficacy of Ifnα in JAK2 V617F and Calr -Mutated MPN Patients

Blood (2019) 134 (Supplement_1): 4196.

https://doi.org/10.1182/blood-2019-127903

Published: 2019

Journal Articles

A Phase 1 Study Evaluating BI 765063, a First in Class Selective Myeloid Sirpa Inhibitor, As Stand-Alone and in Combination with BI 754091, a Programmed Death-1 (PD-1) Inhibitor, in Patients with Advanced Solid Tumours

Jean-Pierre Delord, MD, Nuria Kotecki, MD, Aurelien Marabelle, MD PhD, Armelle Vinceneux, MD, Iphigenie Korakis, MD, Christiane Jungels, MD, Stéphane Champiat, MD, Richard D. Huhn, MD, Nicolas Poirier, PhD, Dominique Costantini, MD, Bérangère Vasseur, MD, Philippe A. Cassier, MD

Blood (2019) 134 (Supplement_1): 1040.

https://doi.org/10.1182/blood-2019-124876

Published: 2019

Journal Articles

Deep DNA Sequencing Identifies Small Mutations in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Analysis of Intratumor Genomic Heterogeneity for Prediction of Disease Relapse

Athena Kritharis, MD, Sukhdeep Kaur, MD, Jui Wan Loh, BS, Mohammad Hadigol, PhD, Hossein Khiabanian, PhD, Roger Strair, MD PhD

Blood (2019) 134 (Supplement_1): 1445.

https://doi.org/10.1182/blood-2019-126303

Published: 2019

Journal Articles

SIRT6 As a Potential Therapeutic Target in Diffuse Large B-Cell Lymphoma

Juan Yang, PhD, Ying Li, MD, Ya Zhang, MD, Xiangxiang Zhou, MD, Xin Wang, MD PhD

Blood (2018) 132 (Supplement 1): 2862.

https://doi.org/10.1182/blood-2018-99-115823

Published: 2018

Journal Articles

Dynamic Personalized Assessment of Outcome in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Blood (2018) 132 (Supplement 1): 2695.

https://doi.org/10.1182/blood-2018-99-115212

Published: 2018

Journal Articles

The Irish Personalized Approach to the Treatment of Haemophilia (iPATH) - Determinants of Inter-Individual Variation in FVIII Pharmacokinetics

Michelle Lavin, MB, PhD FRCPath, Niamh Larkin, Anjali Patel, Evelyn Singleton, Mary Byrne, Kevin Ryan, MB, FRCPath, Niamh M O'Connell, MB, PhD FRCPath, Birgit M Reipert, Steven Pipe, Peter L Turecek, PhD, James S O'Donnell, MD PhD

Blood (2018) 132 (Supplement 1): 1190.

https://doi.org/10.1182/blood-2018-99-112850

Published: 2018

Journal Articles

Bayesian Analysis of TPO Levels in Immune Thrombocytopenia

George Adams, MBChB, Adam Gosztolai, PhD, Elisa Lucchini, MD, Anwar A. Sayed, MBBS, MSc, Amna Malik, PhD, Nichola Cooper, MRCP

Blood (2018) 132 (Supplement 1): 1157.

https://doi.org/10.1182/blood-2018-99-113454

Published: 2018

Journal Articles

Dynamic Personalized Assessment in Patients with Chronic Myeloid Leukemia in Chronic Phase

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Marina Y. Konopleva, MD PhD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, William G. Wierda, MD PhD, Naval G. Daver, MD, Alessandra Ferrajoli, MD, Koichi Takahashi, MD, Guillermo Montalban-Bravo, MD, Mary B. Rios, RN, Sherry A. Pierce, BSN, BA, Kenichi Sakurai, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2018) 132 (Supplement 1): 3026.

https://doi.org/10.1182/blood-2018-99-115380

Published: 2018

Journal Articles

Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants: A Traditional and Network Meta-Analysis

Zachary Wolfe, MD, Fahad Nasir, MD, Charumathi Subramanian, MD, Safi Khan, MD, Bradley W. Lash, MD

Blood (2017) 130 (Supplement 1): 2387.

https://doi.org/10.1182/blood.V130.Suppl_1.2387.2387

Published: 2017

Journal Articles

Vemurafenib in Advanced Patients with Hairy Cell Leukemia (HCL): Results of the Acsé Phase II Trial

Xavier Troussard, MD, Laure Montané, Mourad Tiab, Carine Chaleteix, MD, Isabelle Grulois, Clothilde Lindet, Delphine Legoupil, Frederic Kohser, Diane Pannier, Frederic Maloisel, Pierre Bories, Céline AIT Oukhatar, Natalie Hoog Labouret, Jean-Yves Blay, MD PhD

Blood (2017) 130 (Supplement 1): 156.

https://doi.org/10.1182/blood.V130.Suppl_1.156.156

Published: 2017

Journal Articles

Phase II Study of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) at High Risk for Induction Mortality

Gautam Borthakur, MD, Hagop M. Kantarjian, MD, Courtney D. DiNardo, MDMSc, Naval Daver, MD, Elias J. Jabbour, MD, Tapan Kadia, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MBBS, Naveen Pemmaraju, MD, Marina Konopleva, MD PhD, Maro Ohanian, DO, William G Wierda, MD PhD, Nitin Jain, MD, Lian-Chun Xiao, Paromita Mukherjee, Mark Brandt, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 892.

https://doi.org/10.1182/blood.V130.Suppl_1.892.892

Published: 2017

Journal Articles

Population Pharmacokinetics Profiling to Tailor Prophylaxis in Hemophilia a Patients: A Pilot Feasibility Study

Michaela Stemberger, Felix Kallenbach, Elisabeth Schmit, Alanna McEneny-King, Andrea N Edginton, PhD, Alfonso Iorio, MD PhD, Karin Kurnik

Blood (2017) 130 (Supplement 1): 2404.

https://doi.org/10.1182/blood.V130.Suppl_1.2404.2404

Published: 2017

Journal Articles

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Anti-Ferroportin Antibody in Patients with Anemia Due to Chronic Renal Failure

Philip Barrington, BM, MFPM, Matthew J Sheetz, MD PhD, Sophie Callies, PhD PharmD, D G Waters, Paul H Berg, MS, Donna Pappas, Thomas C Marbury, MD, Brian S Decker, MD PharmD, Jolene Kay Berg, MD

Blood (2016) 128 (22): 1280.

https://doi.org/10.1182/blood.V128.22.1280.1280

Published: 2016

Journal Articles

A Phase I Trial of Janus Kinase (JAK) Inhibition with INCB039110 in Acute Graft-Versus-Host Disease (aGVHD)

Mark A. Schroeder, MD, H. Jean Khoury, MD FACP, Madan Jagasia, MD MS, Haris Ali, MD, Gary J. Schiller, MD, Michael Arbushites, Patricia Delaite, Ying Yan, Kathleen Rhein, Miguel-Angel Perales, MD, Yi-Bin Chen, MD, John F DiPersio, MD PhD

Blood (2016) 128 (22): 390.

https://doi.org/10.1182/blood.V128.22.390.390

Published: 2016

Journal Articles

Clinical Next Generation Sequencing to Identify Novel Platelet Disorders

Kathleen Freson, PhD

Blood (2016) 128 (22): SCI-38.

https://doi.org/10.1182/blood.V128.22.SCI-38.SCI-38

Published: 2016

Journal Articles

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Juan Eduardo Megías-Vericat, PharmD, María Remedios Marqués, PhD, Saturnino Haya, MD, Ana Rosa Cid, MD, Felipe Querol, MD, Emilio Monte, PhD, María García-Dasí, Patricia Caunedo, Carmen Vila, Pau Bosch, Rafael Curats, Miguel Ángel Sanz, MD PhD, José Luis Poveda, PhD, Santiago Bonanad, MD

Blood (2016) 128 (22): 3802.

https://doi.org/10.1182/blood.V128.22.3802.3802

Published: 2016

Journal Articles

Bayesian Estimation of Pharmacokinetic Parameters in Children and Adolescents with Severe Hemophilia: A Single Center Experience

Ihosvany Fernandez Bello, PhD, María Teresa Álvarez Román, PhD, Monica Martín Salces, Nora Butta, PhD, María Isabel Rivas Pollmar, Miguel Canales, PhD, Victor Jiménez Yuste, PhD

Blood (2015) 126 (23): 3534.

https://doi.org/10.1182/blood.V126.23.3534.3534

Published: 2015

Journal Articles

Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia

Patrick T. McGann, MD MS, Min Dong, PhD, Russell E. Ware, MD PhD, Alexander A Vinks, PharmD, PhD

Blood (2015) 126 (23): 982.

https://doi.org/10.1182/blood.V126.23.982.982

Published: 2015

Journal Articles

Molecular Subgroups of Hyperdiploidy and Their Prognostic Relevance - an Analysis of 1,036 Myeloma Trial Patients

Martin F Kaiser, MD, Eileen Mary Boyle, MD PhD, Brian A Walker, PhD, Dil B Begum, Paula Proszek, David C Johnson, PhD, Charlotte Pawlyn, MB BChir, John R Jones, MD, Suvi Savola, PhD, Roger G Owen, Mark T Drayson, MD PhD, David A Cairns, Gordon Cook, MD PhD, Walter M Gregory, Richard S Houlston, MDPhDFRCP, Faith E Davies, MD, Graham H Jackson, MD, Gareth J Morgan, MD PhD

Blood (2015) 126 (23): 2983.

https://doi.org/10.1182/blood.V126.23.2983.2983

Published: 2015

NARROW

Open Label Non-Randomized Phase II Study Exploring «Chemo-Free » Treatment Association with Idelalisib + Obinutuzumab in Patients with Relapsed/Refractory (R/R) Waldenstrom's Macroglobulinemia (MW), a Filo Trial: Results of the Intermediary Analysis of the Induction Phase

Predicting the Long-Term Efficacy of Ifnα in JAK2 V617F and Calr -Mutated MPN Patients

A Phase 1 Study Evaluating BI 765063, a First in Class Selective Myeloid Sirpa Inhibitor, As Stand-Alone and in Combination with BI 754091, a Programmed Death-1 (PD-1) Inhibitor, in Patients with Advanced Solid Tumours

Deep DNA Sequencing Identifies Small Mutations in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Analysis of Intratumor Genomic Heterogeneity for Prediction of Disease Relapse

SIRT6 As a Potential Therapeutic Target in Diffuse Large B-Cell Lymphoma

Dynamic Personalized Assessment of Outcome in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

The Irish Personalized Approach to the Treatment of Haemophilia (iPATH) - Determinants of Inter-Individual Variation in FVIII Pharmacokinetics

Bayesian Analysis of TPO Levels in Immune Thrombocytopenia

Dynamic Personalized Assessment in Patients with Chronic Myeloid Leukemia in Chronic Phase

Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants: A Traditional and Network Meta-Analysis

Vemurafenib in Advanced Patients with Hairy Cell Leukemia (HCL): Results of the Acsé Phase II Trial

Phase II Study of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) at High Risk for Induction Mortality

Population Pharmacokinetics Profiling to Tailor Prophylaxis in Hemophilia a Patients: A Pilot Feasibility Study

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Anti-Ferroportin Antibody in Patients with Anemia Due to Chronic Renal Failure

A Phase I Trial of Janus Kinase (JAK) Inhibition with INCB039110 in Acute Graft-Versus-Host Disease (aGVHD)

Clinical Next Generation Sequencing to Identify Novel Platelet Disorders

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Bayesian Estimation of Pharmacokinetic Parameters in Children and Adolescents with Severe Hemophilia: A Single Center Experience

Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia

Molecular Subgroups of Hyperdiploidy and Their Prognostic Relevance - an Analysis of 1,036 Myeloma Trial Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only